Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The phosphorylated prodrug FTY720 is a histone deacetylase inhibitor that reactivates ERα expression and enhances hormonal therapy for breast cancer
Nitai C. Hait, Dorit Avni, Akimitsu Yamada, et al.
Oncogenesis (2015) Vol. 4, Iss. 6, pp. e156-e156
Open Access | Times Cited: 95

Showing 26-50 of 95 citing articles:

Self-activating chitosan-based nanoparticles for sphingosin-1 phosphate modulator delivery and selective tumor therapy
Hossein Mahmudi, Mohammad Shahpouri, Mohammad Amin Adili-Aghdam, et al.
International Journal of Biological Macromolecules (2024) Vol. 272, pp. 132940-132940
Closed Access | Times Cited: 5
FTY720/fingolimod increases NPC1 and NPC2 expression and reduces cholesterol and sphingolipid accumulation in Niemann‐Pick type C mutant fibroblasts
Jason Newton, Nitai C. Hait, Michael Maceyka, et al.
The FASEB Journal (2017) Vol. 31, Iss. 4, pp. 1719-1730
Open Access | Times Cited: 45
Sphingosine-1-phosphate and estrogen signaling in breast cancer
Melissa A. Maczis, Sheldon Milstien, Sarah Spiegel
Advances in Biological Regulation (2015) Vol. 60, pp. 160-165
Open Access | Times Cited: 44
Nuclear lipid mediators: Role of nuclear sphingolipids and sphingosine‐1‐phosphate signaling in epigenetic regulation of inflammation and gene expression
Panfeng Fu, David L. Ebenezer, Alison W. Ha, et al.
Journal of Cellular Biochemistry (2018) Vol. 119, Iss. 8, pp. 6337-6353
Open Access | Times Cited: 43
Sphingosine kinase 1 in breast cancer
Kurt Geffken, Sarah Spiegel
Advances in Biological Regulation (2017) Vol. 67, pp. 59-65
Open Access | Times Cited: 42
Sphingosine-1-phosphate signaling: A novel target for simultaneous adjuvant treatment of triple negative breast cancer and chemotherapy-induced neuropathic pain
Sandeep K. Singh, Sarah Spiegel
Advances in Biological Regulation (2019) Vol. 75, pp. 100670-100670
Open Access | Times Cited: 38
Current Challenges in Understanding the Cellular and Molecular Mechanisms in Niemann–Pick Disease Type C1
Anja U. Bräuer, Angela Kuhla, Carsten Holzmann, et al.
International Journal of Molecular Sciences (2019) Vol. 20, Iss. 18, pp. 4392-4392
Open Access | Times Cited: 36
Hormonal and Genetic Regulatory Events in Breast Cancer and Its Therapeutics: Importance of the Steroidogenic Acute Regulatory Protein
Pulak R. Manna, Ahsen U. Ahmed, Deborah Molehin, et al.
Biomedicines (2022) Vol. 10, Iss. 6, pp. 1313-1313
Open Access | Times Cited: 20
Melanophilin inhibit the growth and lymph node metastasis of triple negative breast cancer via the NONO-SPHK1-S1P axis
Xing Yao, Tiffany Yuen, Qingchuan Chen, et al.
Journal of Translational Medicine (2025) Vol. 23, Iss. 1
Open Access
Micro-RNAs targeting the estrogen receptor alpha involved in endocrine therapy resistance in breast cancer
Juan Manuel Márquez-Mendoza, Noemi Baranda-Ávila, Marcela Lizano, et al.
Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease (2025), pp. 167783-167783
Closed Access
Drug Resistance: The Role of Sphingolipid Metabolism
Assem Zhakupova, Adelina Zeinolla, Kamilya Kokabi, et al.
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 8, pp. 3716-3716
Open Access
The inhibition of histone deacetylase 8 suppresses proliferation and inhibits apoptosis in gastric adenocarcinoma
Shiyuan Song, Ying Wang, Po Xu, et al.
International Journal of Oncology (2015) Vol. 47, Iss. 5, pp. 1819-1828
Open Access | Times Cited: 39
Sphingosine kinase 1 activation by estrogen receptor α36 contributes to tamoxifen resistance in breast cancer
Melissa A. Maczis, Michael Maceyka, Michael R. Waters, et al.
Journal of Lipid Research (2018) Vol. 59, Iss. 12, pp. 2297-2307
Open Access | Times Cited: 35
Regulatory role of sphingosine kinase and sphingosine-1-phosphate receptor signaling in progenitor/stem cells
Mah Lee Ng, Nagendra Sastry Yarla, Mario Menschikowski, et al.
World Journal of Stem Cells (2018) Vol. 10, Iss. 9, pp. 119-133
Open Access | Times Cited: 34
Sexually dimorphic therapeutic response in bortezomib-induced neuropathic pain reveals altered pain physiology in female rodents
Katherine Stockstill, Carrie Wahlman, Kathryn Braden, et al.
Pain (2019) Vol. 161, Iss. 1, pp. 177-184
Open Access | Times Cited: 34
More than Just an Immunosuppressant: The Emerging Role of FTY720 as a Novel Inducer of ROS and Apoptosis
Teruaki Takasaki, Kanako Hagihara, Ryosuke Satoh, et al.
Oxidative Medicine and Cellular Longevity (2018) Vol. 2018, Iss. 1
Open Access | Times Cited: 33
Targeting HDAC/OAZ1 axis with a novel inhibitor effectively reverses cisplatin resistance in non-small cell lung cancer
Yuhong Sun, Xuefei Bao, Yong Ren, et al.
Cell Death and Disease (2019) Vol. 10, Iss. 6
Open Access | Times Cited: 33
Role of Sphingosine Kinase 1 and Sphingosine-1-Phosphate Axis in Hepatocellular Carcinoma
Michael Maceyka, Timothy D. Rohrbach, Sheldon Milstien, et al.
Handbook of experimental pharmacology (2019), pp. 3-17
Open Access | Times Cited: 32
Regulation of hypoxia‐inducible factor functions in the nucleus by sphingosine‐1‐phosphate
Nitai C. Hait, Aparna Maiti, Pan Xu, et al.
The FASEB Journal (2020) Vol. 34, Iss. 3, pp. 4293-4310
Open Access | Times Cited: 32
Orthotopic Implantation Achieves Better Engraftment and Faster Growth Than Subcutaneous Implantation in Breast Cancer Patient-Derived Xenografts
Maiko Okano, Masanori Oshi, Ali Butash, et al.
Journal of Mammary Gland Biology and Neoplasia (2020) Vol. 25, Iss. 1, pp. 27-36
Open Access | Times Cited: 28
Emerging Roles of Ceramides in Breast Cancer Biology and Therapy
Purab Pal, G. Ekin Atilla‐Gokcumen, Jonna Frasor
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 19, pp. 11178-11178
Open Access | Times Cited: 17
FTY720/Fingolimod mitigates paclitaxel‐induced Sparcl1‐driven neuropathic pain and breast cancer progression
Sandeep K. Singh, Cynthia Weigel, Ryan Brown, et al.
The FASEB Journal (2024) Vol. 38, Iss. 15
Open Access | Times Cited: 3
FTY720 (Fingolimod) reverses α-synuclein-induced downregulation of brain-derived neurotrophic factor mRNA in OLN-93 oligodendroglial cells
Ismael Segura‐Ulate, Barbara Yang, Javier Vargas‐Medrano, et al.
Neuropharmacology (2017) Vol. 117, pp. 149-157
Open Access | Times Cited: 32
Sphingolipids and their enigmatic role in asthma
Jamie Sturgill
Advances in Biological Regulation (2018) Vol. 70, pp. 74-81
Open Access | Times Cited: 31
S1PR1 predicts patient survival and promotes chemotherapy drug resistance in gastric cancer cells through STAT3 constitutive activation
Shiyu Song, Haiyan Min, Mengyuan Niu, et al.
EBioMedicine (2018) Vol. 37, pp. 168-176
Open Access | Times Cited: 30

Scroll to top